This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Enteroinvasive E. coli

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Enteroinvasive E. coli cause a dysentery-like illness by invading the epithelial cells of the large intestine where they cause necrosis, ulceration and inflammation.

They cause sporadic outbreaks of diarrhoea in older children and adults, some of which are food-borne.

Enteroinvasive serotypes include 0124, 0136, 0143 etc.

Reservoir:

  • Gastrointestinal tract of humans and animals

Epidemiology:

  • may be associated with travel to developing countries
  • may cause cases of gastroenteritis and outbreaks in developed countries

Transmission:

  • faecal-oral from person to person (EPEC), foodborne (ETEC, EPEC, EIEC) or waterborne (ETEC, EPEC, EIEC) spread

Incubation period:

  • Reported range from 1 hour to 7 days. Most cases within about 10-50 hours (ETEC, EIEC) or about 8-18 hours (EPEC, EAEC)

Common clinical features:

  • Diarrhoea (all types), often watery. Abdominal pain common (ETEC, EPEC, EIEC). Nausea, vomiting and fever may occur (all) and/or blood and mucus (EIEC, EAEC)

Infectivity:

  • Whilst symptomatic and for 48 hours after diarrhoea has stopped

Notes:

  • Excretion often longer than 48 hours after remission, but infectious risk low if normal stools

Reference:

  • PHE (2019). Recommendations for the Public Health Management of Gastrointestinal Infections

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.